Entrada Therapeutics Income Statement (2022-2025) | TRDA

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 25.26M18.17M43.73M41.85M59.12M94.69M19.57M37.40M20.56M1.95M1.61M
Operating items
Research & Development 15.72M16.25M18.96M15.69M23.10M26.30M22.19M28.29M28.61M32.03M31.26M33.41M32.07M37.88M38.36M
Selling, General & Administrative 6.43M7.33M6.98M9.89M7.94M8.17M7.53M8.65M9.40M9.24M9.97M9.86M10.27M10.92M10.30M
Operating Expenses 22.15M23.58M25.94M25.58M31.04M34.47M29.72M36.94M38.01M41.27M41.23M43.27M42.35M48.80M48.66M
Operating Income -22.15M-23.58M-25.94M-25.58M-5.78M-16.30M14.01M4.91M21.11M53.42M-21.66M-5.87M-21.79M-46.85M-47.05M
EBIT -22.15M-23.58M-25.94M-25.58M-5.78M-16.30M14.01M4.91M21.11M53.42M-21.66M-5.87M-21.79M-46.85M-47.05M
Non-operating items
Interest & Investment Income 0.48M0.40M0.80M0.95M2.66M4.22M4.05M4.29M4.21M4.37M5.77M5.13M4.44M3.92M3.57M
Other Non Operating Income 0.48M0.40M0.80M0.95M2.66M4.22M4.05M4.29M4.21M4.37M5.77M5.13M4.44M3.92M3.57M
Non Operating Income 0.48M0.40M0.80M0.95M2.66M4.22M4.05M4.29M4.21M4.37M5.77M5.13M4.44M3.92M3.57M
Net income details
EBT -21.67M-23.18M-25.14M-24.63M-3.12M-12.08M18.06M9.24M25.33M57.79M-15.89M-0.72M-17.35M-42.92M-43.48M
Tax Provisions 3.60M13.85M-17.40M18.74M1.83M2.80M-1.90M-1.83M0.20M0.70M
Profit After Tax -21.70M-23.18M-25.14M-24.63M-6.67M-25.93M35.46M-9.54M23.50M55.03M-14.03M1.13M-17.35M-43.10M-44.13M
Income from Continuing Operations -21.67M-23.18M-25.14M-24.63M-6.72M-25.93M35.46M-9.50M23.50M54.99M-13.99M1.10M-17.35M-43.12M-44.18M
Consolidated Net Income -21.67M-23.18M-25.14M-24.63M-6.72M-25.93M35.46M-9.50M23.50M54.99M-13.99M1.10M-17.35M-43.12M-44.18M
Income towards Parent Company -21.67M-23.18M-25.14M-24.63M-6.72M-25.93M35.46M-9.50M23.50M54.99M-13.99M1.10M-17.35M-43.12M-44.18M
Net Income towards Common Stockholders -21.67M-23.18M-25.14M-24.63M-6.72M-25.93M35.46M-9.50M23.50M54.99M-13.99M1.10M-17.35M-43.12M-44.18M
Additional items
EPS (Basic) -0.69-0.74-0.80-0.78-0.21-0.781.07-0.290.701.61-0.35-0.03-0.42-1.04-1.06
EPS (Weighted Average and Diluted) -0.69-0.74-0.80-0.78-0.21-0.781.02-0.280.681.55-0.35-0.04-0.42-1.04-1.06
Shares Outstanding (Weighted Average) 31.25M31.37M31.37M33.08M33.20M33.20M33.27M33.37M33.60M33.76M37.42M37.42M37.59M37.95M38.04M
Shares Outstanding (Diluted Average) 31.25M31.28M31.30M31.29M32.37M33.16M34.78M33.05M34.79M35.51M40.63M39.00M41.07M41.34M41.46M
EBITDA -23.21M-23.91M-25.62M-23.94M-5.26M-26.29M35.97M-8.85M23.05M54.95M-12.73M0.12M-16.87M-43.14M-43.91M
Tax Rate 7.23%4.85%11.96%